1 |
Subjects aged 18 years and below 55 years of age |
1 |
Subject who has received any type of rabies vaccination in the past. |
2 |
Subjects with either category II or category III exposures to rabies |
2 |
Pregnancy and lactation |
3 |
Subjects willing to sign informed consent |
3 |
Subject has received rabies immunoglobulin (human/equine) in the past |
4 |
Subjects available for one year follow-up period and willing to give blood samples on recommended days |
4 |
Subject is suffering from chronic diseases like diabetes mellitus, hypertension and tuberculosis |
5 |
Subject with animal bite cases reported within 72 hours of exposure |
5 |
Subject on steroids, anticancer drugs and radiation therapy or any other immunosuppressant or immune compromised |
6 |
Subject is on concomitant antimalarial drugs |
7 |
Subject with history of allergy to any ingredient of the vaccine |
8 |
Subject in other clinical trial in the past 3 months |